Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Cybin Inc. N.CYBN

Alternate Symbol(s):  CYBN

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: TSX snaps six-day selloff
A day after posting its longest streak of daily declines since May, Canada’s main stock index rose on Wednesday led by precious metal miners and technology stocks. Utilities was the only sector to... read article.
@ the Bell: TSX couldn't keep its head above water
The energy and metals sectors did the heavy lifting for Canada’s main stock index on Tuesday. The health care sector also moved higher while the rest of the field closed in the red. Today in the... read article.

International Independent Oil & Gas Company Provides Production Update

The Company has drilled 20 gross wells as part of its expanded 2022 drilling program. Of these wells 13 are on production, 5 are being cleaned up following tie in and 2 await completion. The latter 7 wells are expected to be fully cleaned up and on production in late October. ...read more

New Press Release - Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds

– Provides access to large catalog of compounds complementary to Company’s preclinical assets –– Strengthens drug discovery and development platform to build future potential novel drug candidates –– Supports broad intellectual property portfolio of innovative psychedelic-based molecules – Cybin...read article.

New Press Release - Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Licensing Subset of Mindset’s Family 1 Intellectual Property Underscores Strength of Mindset’s Portfolio and Business Strategy TORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset”), a drug discovery company developing novel, optimized...read article.
Buzz on the Bullboards: Cooler days doesn’t mean cooler markets
The autumn season officially starts today and the business world along with the Bullboards have certainly picked up in activity.Every week we track the most-viewed Bullboards in each sector and... read article.

New Press Release - Cybin to Participate in Upcoming Scientific and Investor Conferences

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, is pleased to announce its participation in the following upcoming conferences: Interdisciplinary Conference on Psychedelic Research...read article.

New Press Release - Cybin Achieves Research and Development Milestones Ahead of Projected Timelines

-- Completion of Adelia milestones marks promising path toward clinical drug development -- Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, announced that it has successfully achieved its...read article.

RE:RE:RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

  rate and reply

RE:RE:RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

So what your saying is that this company SILO Wellness a nostril sprayy that has psilocybin in it? Jesus, this is pretty dope. Added to my MUSH watchlist. To date so far have not heard of any other...read more

RE:RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

https://www.silowellness.com/nasal-spray/ The Company has received feedback from potential licensees with interest in a pharmaceutical use for the nasal spray.   Silo Wellness has developed...read more

RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

  rate and reply

RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

Hey, thanks alot for Insight! A psilocybin nasal spray sounds promising. I am looking to invest about 5k in the shroom stocks from my recently free cash of 17k float. Any idea when they will be...read more

$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

Founded in 2018, Silo Wellness offers a diverse and growing portfolio of functional mushroom products, psychedelic wellness retreats in Jamaica and Oregon, cultivation of psychedelic mushrooms and...read more

Next Shroom Stock to Blow: $Silo 𓋼𓋺📈𓋺𓋼 SILO WELLNESS

Volume says it all.  Fidelity has been buying major.  News Soon :-D  rate and reply

Microdose Announces The 2nd Annual Microdose Awards

Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is excited to announce the lineup of categories for the 2nd...read more

New Press Release - Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, announced today that enrollment has begun in a Phase 1/2a clinical trial of CYB003, the first novel psilocybin analog to be...read article.

New Press Release - Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical

-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today...read article.

New Press Release - Cybin Announces Additional Adelia Milestone Achievement

Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing Psychedelics to Therapeutics™, is pleased to announce that Adelia Therapeutics Inc. (“Adelia”), a wholly-controlled subsidiary of Cybin, has achieved the milestone identified as...read article.

New Press Release - Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder

-- Marks the first novel psilocybin analog to enter clinical development -- -- Patient recruitment to commence immediately -- -- Pharmacokinetic and safety data readout expected in Q4 2022 -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company...read article.

New Press Release - Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights

- Company reiterates key pipeline and strategic milestones for 2022 – Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, today reported audited financial results for its fiscal year ended...read article.

RE:RE:Quiet Over Here. New Member needs Advice...

hi gajjardr, would you be able to explain why you feel so sure?  anything would be helpful, thanks. dug  rate and reply

RE:RE:Quiet Over Here. New Member needs Advice...

I just took a look at this company suggestion. Nice cheapie. Volume on all Shroom stocks has bottomed out only because people are awaiting the Health Canada studies. It's pretty obvious what will...read more

RE:Quiet Over Here. New Member needs Advice...

LOBE 100%  rate and reply